Effect of policosanol on carbon tetrachloride-induced acute liver damage in Sprague-Dawley rats

Drugs in R and D

Volumn 4, Issue 1, 2003, Pages 29-35

  Noa, Miriam ^a   Mendoza, Sarahí ^a   Más, Rosa ^a   Mendoza, Nilda ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CARBON TETRACHLORIDE; HYPOCHOLESTEROLEMIC AGENT; LIVER ENZYME; LIVER PROTECTIVE AGENT; LOW DENSITY LIPOPROTEIN; OLIVE OIL; PLANT EXTRACT; POLICOSANOL; SUGARCANE EXTRACT; UNCLASSIFIED DRUG; FATTY ALCOHOL;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL COUNT; CELL INCLUSION; CELL SWELLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG PURIFICATION; DRUG SAFETY; DRUG TOLERABILITY; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LIPID PEROXIDATION; LIVER CELL; LIVER FUNCTION; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; RANDOMIZATION; RAT; STATISTICAL ANALYSIS; SUGARCANE; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; LIVER; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARBON TETRACHLORIDE; FATTY ALCOHOLS; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0041355283     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200304010-00003     Document Type: Article

References (41)

1. Plaa GL, Hewitt WR. Detection and evaluation of chemically induced liver injury. In: Wallace Hayes A, editor. Principles and methods of toxicology. 2nd ed. 1989; New York, Raven Press, Ltd: 599-628
2. Recknagel RO, Glende EA, Waller RL, Lowry K. Lipid peroxidation: biochemistry, measurement, and significance in liver cell injury. In: Plaa G, Hewitt WR, editors. Toxicology of the liver. New York: Raven Press, 1982: 213-241
3. Wendel A. Measurement of in vivo lipid peroxidation and toxicological significance. Free Radic Biol Med 1987; 3: 355-8
4. Menéndez R, Fraga V, Sotolongo V, et al. Efecto de la administración oral del policosanol sobre el metabolismo lipídico de ratas normocolesterolémicas. Rev Mex Cien Farm 1993; 24: 16-8
5. Menéndez R, Fernández SI, Del Rio A, et al. Policosanol inhibits cholesterol biosynthesis and enhances LDL processing in cultured human fibroblasts. Biol Res 1994; 27: 199-203
6. Menéndez R, Arruzazabala ML, Más R, et al. Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolemia induced by a wheat starch-casein diet. Br J Nutr 1997; 77: 923-32
7. Menéndez R, Amor A, Rodeiro I, et al. Policosanol modulates HMGCoA reductase activity in cultured fibroblasts. Arch Med Res 2001; 32: 8-12
8. Castaño G, Canetti M, Morera M, et al. Efficacy and tolerability of policosanol in elderly patients with type II hypercholesterolemia: a 12 months study. Curr Ther Res 1993; 56: 819-28
9. Pons P, Rodríguez M, Robaina C, et al. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolemia and tolerability to treatment. Int J Clin Pharmacol Res 1994; XIV: 27-33
10. Aneiros E, Más R, Calderón B, et al. Effect of policosanol in lowering-cholesterol levels in patients with type II hypercholesterolemia. Curr Ther Res 1995; 56: 176-82
11. Canetti M, Morera M, Illnait J, et al. One year study on the effect of policosanol (5mg-twice-a-day) on lipid profile in patients with type II hypercholesterolemia. Adv Ther 1995; 12: 245-54
12. Castaño G, Tula L, Canetti M, et al. Effects of policosanol in hypertensive patients with type II hypercholesterolemia. Curr Ther Res 1996; 57: 691-9
13. Zardoya R, Tula L, Castaño G, et al. Effects of policosanol on hypercholesterolemic patients with disturbances on serum biochemical indicators of hepatic function. Curr Ther Res 1996; 57: 568-77
14. Ortensi G, Gladstein H, Valli H, et al. A comparative study of policosanol versus simvastatin in elderly patients with hypercholesterolemia. Curr Ther Res 1997; 58: 390-401
15. Canetti M, Morera MS, Más R, et al. Effects of policosanol on primary hypercholesterolemia: a 3 year open follow-up. Curr Ther Res 1997; 58: 868-75
16. Más R, Castaño G, Illnait J, et al. Effects of policosanol on patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther 1999; 65: 439-47
17. Castaño G, Más R, Fernández JC, et al. A long-term open study of the efficacy and tolerability of policosanol in patients with high global coronary risk. Curr Ther Res 1999; 60: 379-91
18. Castaño G, Más R, Arruzazabala ML, et al. Effects of policosanol, pravastatin on lipid profile, platelet aggregation, endothelemia in older hypercholesterolemic patients. Int J Clin Pharm Res 1999; 19: 105-16
19. Castaño G, Más R, Fernández JC, et al. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk. J Gerontol A Biol Sci Med Sci 2001; 56: M186-92
20. Torres O, Agramonte AJ, Illnait J, et al. Treatment of hypercholesterolemia in NIDDM with policosanol. Diabetes Care 1995; 18: 393-7
21. Crespo N, Alvarez R, Más R, et al. Effect of policosanol on patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia: a pilot study. Curr Ther Res 1997; 58: 44-51
22. Crespo N, Illnait J, Mas R, et al. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and non insulin dependent diabetes mellitus. Int J Clin Pharmacol Res 1999; 19: 105-16
23. Mas R. Policosanol. Drugs Fut 2000; 25: 569-86
24. Arruzazabala ML, Carbajal D, Más R, et al. Effects of policosanol on platelet aggregation in rats. Thromb Res 1993; 69: 321-7
25. Arruzazabala ML, Carbajal D, Molina V, et al. Effect of policosanol on cerebral ischemia in mongolian gerbils: role of prostacyclin and thromboxane A2. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 695-7
26. Carbajal D, Arruzazabala ML, Valdés S, et al. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers. Prostaglandins Leukot Essent Fatty Acids 1998; 58: 61-4
27. Menéndez R, Fraga V, Amor AM, et al. Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation. Physiol Behav 1999; 67: 1-7
28. Menéndez R, Más R, Amor AM, et al. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro. Br J Clin Pharmacol 2000; 50: 225-62
29. Menéndez R, Más R, Amor A, et al. Effects of policosanol on the low density lipoprotein (LDL) isolated on hypercholesterolemic patients at high coronary risk to in vitro copper-mediated lipid peroxidation: a randomised, double-blinded pilot study. Curr Ther Res 2000; 61: 609-20
30. Alemán CL, Más R, Hernández C, et al. Acute, subchronic and chronic toxicity of policosanol in rats [abstract]. Toxicol Lett 1992; 2: 248
31. Alemán C, Más R, Hernández C, et al. A 12 months study of policosanol oral toxicity in Sprague-Dawley rats. Toxicol Lett 1994; 70: 77-87
32. Gámez R, Alemán CL, Mas R, et al. A 6-month study on the toxicity of high doses of policosanol orally administered to Sprague-Dawley rats. J Med Food 2001; 4: 57-66
33. Alemán CL, Más R, Noa M, et al. Carcinogenicity of policosanol in Sprague Dawley rats: a 24 month study. Teratog Carcinog Mutag 1994; 14: 239-49
34. Alemán C, Puig MN, Elías EC, et al. Carcinogenicity of policosanol in mice: an 18-month study. Food Chem Toxicol 1995; 33: 573-8
35. Coro RM, Borrajero I. DIGIPAT. Un sistema cubano para morfometría de imágenes. Rev Latinoam Patol 1996; 39: 9-10
36. Charbonneau M, Iijima M, Coté MG, et al. Temporal analysis of rat liver injury following potentiation of carbon tetrachloride hepatotoxicity with ketonic or ketogenic compounds. Toxicology 1985; 32: 95-112
37. 4 intoxication. J Appl Toxicol 1984; 4: 270-2
38. Muriel P, Mourelle M. Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol 1990; 10: 275-9
39. Rodeiro I, Alemán CL, Más R, et al. Efectos del policosanol sobre las enzimas microsomales hepáticas en ratas S.D. Revista CENIC Cien Biol 2000; 31: 113-6
40. Pérez-Souto N, Acosta PC, Mederos CM, et al. Efecto del policosanol sobre la famacocinética de la antipirina. Rev CENIC Cien Biol 1991; 22: 77-8
41. Nagai H, Aoki M, Shimazawa T, et al. Effect of Oky-046 and ONO-3708 on liver injury in mice. Jpn J Pharmacol 1989; 51: 191-7